A
DRNA
Abingworth’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-337,825
| Closed | -$973K | – | 18 |
|
2016
Q4 | $973K | Sell |
337,825
-607,932
| -64% | -$1.75M | 0.81% | 16 |
|
2016
Q3 | $5.56M | Hold |
945,757
| – | – | 5.33% | 6 |
|
2016
Q2 | $2.83M | Hold |
945,757
| – | – | 2.96% | 9 |
|
2016
Q1 | $5.06M | Hold |
945,757
| – | – | 4.7% | 6 |
|
2015
Q4 | $11.2M | Hold |
945,757
| – | – | 6.77% | 6 |
|
2015
Q3 | $7.76M | Hold |
945,757
| – | – | 4.53% | 7 |
|
2015
Q2 | $13.2M | Sell |
945,757
-26,977
| -3% | -$376K | 5.98% | 7 |
|
2015
Q1 | $23.4M | Sell |
972,734
-209,462
| -18% | -$5.03M | 9.93% | 4 |
|
2014
Q4 | $19.4M | Hold |
1,182,196
| – | – | 5.52% | 8 |
|
2014
Q3 | $15M | Hold |
1,182,196
| – | – | 8.99% | 5 |
|
2014
Q2 | $26.7M | Hold |
1,182,196
| – | – | 12.4% | 4 |
|
2014
Q1 | $33.3M | Buy |
+1,182,196
| New | +$33.3M | 18.38% | 2 |
|